NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 10122-0325-01 — NICARDIPINE 2 MG/10 ML SOLUTIONAI (190 hospitals, 25,738–25,819 samples)
• NDC 70700-0167-25 — Glycopyrrolate 1 mg per 5 mL injection solutionAI (270 hospitals, 24,976–25,804 samples)
• NDC 49281-0752-22 — Tuberculosis skin test (Tubersol) injectionAI (373 hospitals, 25,132–25,798 samples)
• NDC 51079-0087-01 — Mirtazapine 30 mg oral tabletsAI (244 hospitals, 25,258–25,798 samples)
• NDC 39822-1000-01 — Tranexamic acid 1,000 mg intravenous solutionAI (575 hospitals, 24,429–25,788 samples)
• NDC 65162-0682-10 — Phenazopyridine 200 mg tabletAI (531 hospitals, 24,707–25,787 samples)
• NDC 70004-0231-32 — Fentanyl and bupivacaine nerve-block solutionAI (94 hospitals, 25,081–25,783 samples)
• NDC 63323-0488-89 — Lidocaine with epinephrine numbing injectionAI (103 hospitals, 25,160–25,781 samples)
• NDC 00378-9071-93 — Rivastigmine 9.5 mg/24-hour transdermal patchAI (264 hospitals, 24,942–25,779 samples)
• NDC 70092-1009-44 — Labetalol 20 mg/4 mL IV syringeAI (285 hospitals, 25,040–25,778 samples)
• NDC 70092-9045-05 — Phenylephrine and sodium chloride IV solutionAI (111 hospitals, 25,012–25,777 samples)
• NDC 60687-0231-01 — Sertraline 25 mg tablets, blister pack of 100AI (702 hospitals, 25,094–25,769 samples)
• NDC 23155-0893-31 — Methohexital injection, 500 mg vialAI (81 hospitals, 25,035–25,764 samples)
• NDC 72266-0234-25 — Ketorolac tromethamine 15 mg/mL injectionAI (344 hospitals, 24,117–25,755 samples)
• NDC 00009-0856-05 — Carboprost tromethamine injection 250 mcg/mLAI (448 hospitals, 23,998–25,753 samples)
• NDC 00074-3956-46 — Lopinavir-ritonavir 400/100 mg oral liquidAI (261 hospitals, 24,894–25,749 samples)
• NDC 17478-0420-40 — LABETALOL 5 MG/ML INTRAVENOUS SOLUTIONAI (135 hospitals, 24,677–25,748 samples)
• NDC 44567-0602-24 — Dexmedetomidine in dextrose solution, 50 mL bagAI (132 hospitals, 25,550–25,748 samples)
• NDC 70121-1394-01 — Glycopyrrolate 0.2 mg/mL injectionAI (111 hospitals, 25,045–25,738 samples)
• NDC 72611-0738-01 — LABETALOL 5 MG/ML INTRAVENOUS SOLUTIONAI (57 hospitals, 24,676–25,738 samples)
• NDC 73702-0202-03 — Fentanyl pain medicine mixed in saline for IV useAI (37 hospitals, 24,375–25,734 samples)
• NDC 16714-0897-01 — PERMETHRIN 5 % TOPICAL CREAMAI (320 hospitals, 24,831–25,731 samples)
• NDC 00904-7345-61 — Fluoxetine 10 mg capsulesAI (356 hospitals, 25,089–25,728 samples)
• NDC 00003-0494-20 — Kenalog-10 triamcinolone injectable suspension, 10 mg/mLAI (867 hospitals, 21,947–25,727 samples)
• NDC 00591-5337-01 — TRIHEXYPHENIDYL 5 MG TABLETAI (319 hospitals, 25,132–25,726 samples)
• NDC 59762-5050-07 — Gabapentin 250 mg per 5 mL oral liquidAI (239 hospitals, 24,815–25,724 samples)
• NDC 00008-4001-10 — Pantoprazole 40 mg IV injectionAI (200 hospitals, 25,186–25,717 samples)
• NDC 51672-1304-06 — Terconazole 0.4% vaginal cream, 45 g tubeAI (360 hospitals, 24,810–25,710 samples)
• NDC 69918-0560-30 — MESALAMINE 1,000 MG RECTAL SUPPOSITORYAI (200 hospitals, 24,809–25,700 samples)
• NDC 00338-0214-04 — Intravenous amino acid, dextrose and electrolyte solutionAI (82 hospitals, 25,565–25,700 samples)
• NDC 70095-0024-03 — Pantoprazole 40 mg IV injectionAI (129 hospitals, 25,184–25,697 samples)
• NDC 70954-0212-10 — trihexyphenidyl 2 mg tabletAI (585 hospitals, 25,159–25,690 samples)
• NDC 68682-0920-64 — Tetracaine 0.5% eye drops, 15 mL bottleAI (428 hospitals, 24,835–25,690 samples)
• NDC 00409-4699-50 — propofol 10 mg/mL intravenous emulsionAI (122 hospitals, 24,367–25,690 samples)
• NDC 43598-0165-30 — OLANZAPINE 7.5 MG TABLETAI (229 hospitals, 25,228–25,687 samples)
• NDC 00406-8515-23 — OXYCODONE 15 MG TABLETAI (180 hospitals, 25,228–25,687 samples)
• NDC 00406-8510-23 — oxyCODONE 10 mg tabletAI (163 hospitals, 25,228–25,687 samples)
• NDC 16714-0117-02 — Rivastigmine 13.3 mg/24-hour skin patchAI (85 hospitals, 24,807–25,680 samples)
• NDC 00487-9301-33 — Saline solution for nebulizerAI (584 hospitals, 25,179–25,674 samples)
• NDC 62332-0545-05 — Timolol eye gel (0.25%)AI (185 hospitals, 24,806–25,670 samples)
• NDC 00781-6014-70 — Brinzolamide 1% eye drop suspensionAI (274 hospitals, 24,806–25,670 samples)
• NDC 45802-0131-35 — Halobetasol 0.05% ointment, 15 g tubeAI (107 hospitals, 24,806–25,670 samples)
• NDC 65162-0711-10 — guanFACINE 1 mg tabletAI (311 hospitals, 25,064–25,667 samples)
• NDC 68462-0501-65 — CALCIPOTRIENE 0.005 % TOPICAL CREAMAI (166 hospitals, 24,803–25,667 samples)
• NDC 00078-0841-01 — Ciprofloxacin eye dropsAI (311 hospitals, 24,803–25,667 samples)
• NDC 44567-0622-24 — Calcium gluconate 1 g in 100 mL IV solutionAI (125 hospitals, 25,563–25,662 samples)
• NDC 00378-4642-26 — Estradiol 0.05 mg/24 hour transdermal patchAI (200 hospitals, 24,802–25,657 samples)
• NDC 70069-0007-01 — OLOPATADINE 0.1 % EYE DROPSAI (192 hospitals, 24,802–25,657 samples)
• NDC 00406-8315-62 — Extended-release morphine sulfate 15 mg tabletsAI (564 hospitals, 24,943–25,654 samples)
• NDC 00378-3350-16 — Estradiol 0.05 mg weekly transdermal patchAI (269 hospitals, 24,775–25,648 samples)